Sentence examples for risk stem cells from inspiring English sources

European Union FP7 EURATOM DoReMi network of excellence (249689 to C.B. and S.B ., Risk, Stem Cells and Tissue Kinetics Ionising Radiation (323267 to C.B. and S.B ., an Australian Research Council Future Fellowship (S.L.N ., Victorian State Government Operational Infrastructure Support, Australian Government NHMRC IRIIS (S.L.N).

It seems plausible that the additional risks to stem cells in long-lived species have favoured the evolution of telomere attrition as tumour suppression mechanism (reviewed in Aubert and Lansdorp, 2008).

If only the single marker CK19 mRNA is used, there is a risk that certain highly aggressive cancer stem cells may avoid diagnosis.

The probability of a specific drug-resistant mutation arising will be a function of the intrinsic mutability of that locus and the number of proliferative 'at-risk' cycles in self-renewing cancer stem cells – the necessary repository of selectable mutations (Greaves, 2013).

The report by Servarese and coworkers [ 1], together with other epidemiologic studies, suggests a unifying hypothesis for breast cancer risk related to stem cell number, which is regulated by the growth hormone/IGF-1 axis.

There were no significant differences in the distribution of patient age (p = 0.14), sex match (p = 1.0), race (p = 0.56), disease risk (p = 0.53), stem cell source, CMV serostatus (p = 0.53), conditioning regimen (p = 0.18), or chronic GVHD score (p = 0.23).

The causes for study therapy discontinuation were disease progression (n=20), serious infection (n=5), patient choice (n=3), cardiac medications for atrial fibrillation contraindicating the use of panobinostat due to risk of QTc prolongation (n=2) and stem cell transplantation (n=1).

As previously discussed [ 1], the effective number of stem cells at risk for cancer (N) depends on how often stem cell clonal evolution recurs and is between one and the total number of niche stem cells.

For example, major challenges currently faced within regenerative medicine include the assessment of purity of stem cells or stem cell-derived populations, the former to confirm faithful cellular reprogramming and the latter to eliminate the risk posed by introduction of undifferentiated stem cells in vivo.

NIH stem cell information.

Or stem cell research.